RSCRX Mutual Fund

NAV$31.02

Fund Essentials - as of Jan 31, 2026

Net Assets
$893,940.18
Expense Ratio
0.94%
Dividend Yield (Current)
6.58%
Holdings
1,119
Inception Date
Mar 1, 2016
Fund Family
Russell Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually
SEC 30-Day Yield
••••••••••

Performance

YTD+20.33%
1 Year+40.26%
3 Year+15.63%
5 Year+7.09%
10 Year+11.18%

Asset Allocation

Stocks: 94.78%
Cash: 5.10%
Other: 0.12%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
-U.s. Cash Management Fund5.09%
LGNDLigand Pharmaceuticals, Inc.0.72%
AGXArgan, Inc.0.64%
WTTRSelect Energy Services Inc0.62%
BBIOBridgebio Pharma Inc0.57%
Top 10 Concentration: 10.36%Report Date: Jan 31, 2026
Download all 1119 holdings for RSCRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.58%
Frequency
Annually
Latest Distribution
$9.32
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

RSCRX Mutual Fund Overview

RSCRX Mutual Fund (Russell US Small Cap Equity Fund Class R6) is managed by Russell Investments with $893,940.18 in net assets. RSCRX expense ratio is 0.94%, holding 1119 positions across sectors including Industrials, Financials, Health Care. Inception date: 2016-03-01.

RSCRX performance shows a YTD return of 20.33%. The 1-year return is 40.26% and the 5-year return is 7.09%. RSCRX dividend yield stands at 6.58%, paid annually.

RSCRX top holdings include U.s. Cash Management Fund (5.1%), Ligand Pharmaceuticals, Inc. (0.7%), Argan, Inc. (0.6%), Select Energy Services Inc (0.6%), Bridgebio Pharma Inc (0.6%). View all RSCRX holdings, sector breakdown, or dividend history.

RSCRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RSCRX alternatives are available via the screener, along with tax-loss harvesting opportunities.